Journal article icon

Journal article

Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.

Abstract:

Aspirin has been a commercial drug for over a century, although for most of this history, an understanding of its mechanism of action, as an inhibitor of cyclooxygenase (COX) activity and thus of prostanoid synthesis, was lacking. Over the past fifty years, a large number of other nonsteroidal antiinflammatory drugs (NSAIDs) have been developed, and a much deeper understanding of inflammation and prostanoid action has emerged. Indeed, a new class of selective inhibitors of the cyclooxygenase-...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1124/mi.9.1.8

Authors


Journal:
Molecular interventions
Volume:
9
Issue:
1
Pages:
31-39
Publication date:
2009-02-05
DOI:
EISSN:
1543-2548
ISSN:
1534-0384
URN:
uuid:fa04c388-b1a9-4e0e-98c7-f4524e54af14
Source identifiers:
49485
Local pid:
pubs:49485

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP